| NCT ID | NCT07632014 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Resonance, Inc. |
| Condition | Cancer |
| Study Type | OBSERVATIONAL |
| Enrollment | 6,000 participants |
| Start Date | 2025-11-11 |
| Primary Completion | 2032-11-11 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 6,000 participants in total. It began in 2025-11-11 with a primary completion date of 2032-11-11.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Cancer is a leading cause of illness and death among children, adolescents, and young adults(CAYAs), especially in low- and middle-income countries(LMICs), where access to timely diagnosis and treatment is often limited. As a result, patients in these settings may experience higher rates of treatment complications, interruptions, and poorer outcomes compared with those in high-income countries (HICs). This is a prospective, multicenter observational study that will follow children, adolescents, and young adults(CAYAs) with cancer who are receiving routine care at participating hospitals in low - and middle - income countries(LMICs). The study does not involve experimental treatments or changes to standard medical care. Information will be collected from medical records and from questionnaires that address access to care and social factors affecting treatment. By describing treatment outcomes and the challenges patients and families face during cancer care, this study aims to provide data that can help inform future efforts to improve access to care and cancer outcomes in resource-limited settings.
Eligibility Criteria
Inclusion Criteria: Subjects must meet all the following criteria to be included in this study: 1. Age 0 to 21 years at study enrollment. 2. Diagnosed with cancer and receiving active treatment or undergoing follow-up at the participating sites. a. Note: Patients seen solely for consultation or diagnostic evaluations without subsequent treatment and those who have been off treatment for more than 5 years and are seen only for survivorship follow-up are not considered as meeting this criterion. 3. Willingness to provide informed consent/assent. For minors incapable of providing assent, or individuals unable to provide consent, consent must be obtained from a legal representative and in accordance with local requirements. Exclusion Criteria: Subjects meeting any of the following criteria must be excluded from this study: 1\. Any medical or psychological condition that, in the investigator's opinion, might compromise the ability of the patient to provide assent/informed consent/assent.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07632014 clinical trial?
This trial is open to participants of all sexes, aged 0 Years or older, up to 21 Years, studying Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07632014 currently recruiting?
Yes, NCT07632014 is actively recruiting participants. Contact the research team at gabriela.villanueva@resonancehealth.org for enrollment information.
Where is the NCT07632014 trial being conducted?
This trial is being conducted at Yerevan, Armenia, Cairo, Egypt, Guatemala City, Guatemala.
Who is sponsoring the NCT07632014 clinical trial?
NCT07632014 is sponsored by Resonance, Inc.. The trial plans to enroll 6,000 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.